Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems

Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems

Bibliographic Details
Main Authors:	Elena Argento, Devon Christie, Lindsay Mackay, Cody Callon, Zach Walsh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Psychiatry
Subjects:	psychedelics mental health trauma COVID-19 pandemic psychedelic-assisted psychotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2021.716593/full

Similar Items

Ethical and legal issues in psychedelic harm reduction and integration therapy
by: Brian Pilecki, et al.
Published: (2021-04-01)

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review
by: Laura Orsolini, et al.
Published: (2018-05-01)

Psychedelic revival: a mixed-methods analysis of recreational magic mushroom (psilocybin) use for transformational, micro-dosing and leisure purposes
by: Shaw, Lindsay Victoria
Published: (2018)

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
by: Eduardo Ekman Schenberg
Published: (2018-07-01)

Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature
by: Timothy I. Michaels, et al.
Published: (2018-07-01)

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
by: Leor Roseman, et al.
Published: (2018-01-01)

New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy
by: Tehseen Noorani, et al.
Published: (2021-09-01)

Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy
by: Lauren Lepow, et al.
Published: (2021-09-01)

Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice
by: Ingmar Gorman, et al.
Published: (2021-03-01)

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
by: dos Santos RG, et al.
Published: (2021-03-01)

Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy
by: Tara C. Malone, et al.
Published: (2018-04-01)

The Therapeutic Potential of Psilocybin
by: Henry Lowe, et al.
Published: (2021-05-01)

Current Perspective on the Therapeutic Preset for Substance-Assisted Psychotherapy
by: Sascha B. Thal, et al.
Published: (2021-07-01)

Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
by: Michael P. Bogenschutz, et al.
Published: (2018-02-01)

Psychedelic Telepathy: An Interview Study
by: Petter Grahl Johnstad
Published: (2020-09-01)

Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review
by: Kristin Heuschkel, et al.
Published: (2020-03-01)

Psilocybin and Mental Health–Don't Lose Control
by: Joseph M. Barnby, et al.
Published: (2018-07-01)

The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity
by: Ido Hartogsohn
Published: (2018-03-01)

Behavioral Psychedelics: Integrating Mind and Behavior to Improve Health and Resilience
by: Neuhaus, E.C, et al.
Published: (2022)

Asking questions of psychedelic microdosing
by: Lindsay P Cameron
Published: (2021-03-01)

Lieutenant Butterfly: exploring videogames through ordinary psychedelic play
by: James, Phil
Published: (2015)

Psychedelics as a Treatment for Alzheimer’s Disease Dementia
by: Simon Andrew Vann Jones, et al.
Published: (2020-08-01)

Commentary: Psychedelic Psychiatry's Brave New World
by: Bénédicte Nobile, et al.
Published: (2020-11-01)

Cancer Healthcare Workers’ Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation
by: Lisa M. Reynolds, et al.
Published: (2021-08-01)

Corrigendum: Psychedelics as a Treatment for Alzheimer's Disease Dementia
by: Simon Andrew Vann Jones, et al.
Published: (2020-10-01)

The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder
by: Gyllvik, Sofia
Published: (2020)

The Mechanisms of Psychedelic Visionary Experiences: Hypotheses from Evolutionary Psychology
by: Michael J. Winkelman
Published: (2017-09-01)

Co-design of Guidance for Patient and Public Involvement in Psychedelic Research
by: James B. Close, et al.
Published: (2021-09-01)

Psychedelic Drugs and Atheism: Debunking the Myths
by: Wayne Glausser
Published: (2021-08-01)

Psychedelic microdosing benefits and challenges: an empirical codebook
by: Thomas Anderson, et al.
Published: (2019-07-01)

Psychedelics for Brain Injury: A Mini-Review
by: Shariq Mansoor Khan, et al.
Published: (2021-07-01)

Amazonian Medicine and the Psychedelic Revival: Considering the “Dieta”
by: David M. O’Shaughnessy, et al.
Published: (2021-05-01)

Neuropsychological Functioning in Users of Serotonergic Psychedelics – A Systematic Review and Meta-Analysis
by: Lukas A. Basedow, et al.
Published: (2021-09-01)

Erratum: Psychedelics for Brain Injury: A Mini-Review
by: Frontiers Production Office
Published: (2021-09-01)

Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
by: Cato M. H. de Vos, et al.
Published: (2021-09-01)

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics
by: Emmanuelle A. D. Schindler, et al.
Published: (2018-03-01)

Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
by: Rita Kočárová, et al.
Published: (2021-07-01)

Decreased directed functional connectivity in the psychedelic state
by: Lionel Barnett, et al.
Published: (2020-04-01)

Harm Reduction or Psychedelic Support? Caring for Drug-Related Crises at Transformational Festivals
by: Deirdre Ruane
Published: (2015-06-01)

The Ethic of Access: An AIDS Activist Won Public Access to Experimental Therapies, and This Must Now Extend to Psychedelics for Mental Illness
by: Morgan Campbell, et al.
Published: (2021-07-01)